Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Integra LifeSciences Holdings Corporation - Common Stock (NQ:IART)

17.21 -2.55 (-12.88%)
Streaming Delayed Price Updated: 3:15 PM EDT, Jul 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

All News about Integra LifeSciences Holdings Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
News headline image
Why Integra LifeSciences (IART) Shares Are Sliding Today
What Happened? Shares of medical device company Integra LifeSciences (NASDAQ:IART) fell 10.1% in the afternoon session after the company reported a second-qu... 
Via StockStory
Topics Earnings
News headline image
Integra LifeSciences Q2 Earnings Call Highlights ↗
Integra LifeSciences (NASDAQ:IART) reported second-quarter 2026 revenue of $419 million, up 0.8% on a reported basis and 0.7% organically from a year earlier, as improving supply reliability and... 
Via MarketBeat
Topics Earnings World Trade
Integra LifeSciences (NASDAQ:IART) Surges Over 30% on Q2 Earnings Beat ↗
Via Chartmill
News headline image
Integra LifeSciences’s (NASDAQ:IART) Q2 CY2026 Earnings Results: Revenue In Line With Expectations
Medical device company Integra LifeSciences (NASDAQ:IART) met Wall Street’s revenue expectations in Q2 CY2026, but sales were flat year on year at $418.8 mil... 
Via StockStory
News headline image
Integra LifeSciences (IART) To Report Earnings Tomorrow: Here Is What To Expect
Medical device company Integra LifeSciences (NASDAQ:IART) will be announcing earnings results this Wednesday morning. Here’s what to look for. Integra LifeSc... 
Via StockStory
Topics Artificial Intelligence
News headline image
1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as... 
Via StockStory
News headline image
Kaskela Law Firm Announces Investigation of Integra LifeSciences (IART) and Encourages Long-Term IART Shareholders with Investment Losses to Contact the Firm
From Kaskela Law LLC
Via Business Wire
News headline image
3 Small-Cap Stocks with Warning Signs
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ... 
Via StockStory
News headline image
Why Integra LifeSciences (IART) Stock Is Up Today
What Happened? Shares of medical device company Integra LifeSciences (NASDAQ:IART) jumped 4.3% in the afternoon session after BMO Capital initiated coverage ... 
Via StockStory
Topics Artificial Intelligence Earnings
News headline image
3 Unpopular Stocks with Open Questions
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad t... 
Via StockStory
News headline image
1 Value Stock to Target This Week and 2 We Brush Off
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ... 
Via StockStory
Topics Economy
News headline image
Surgical Equipment & Consumables - Specialty Stocks Q1 Results: Benchmarking Integra LifeSciences (NASDAQ:IART)
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself
From Biotech Insider
Via GlobeNewswire
News headline image
The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It
From World Street Intelligence
Via GlobeNewswire
News headline image
3 Profitable Stocks We’re Skeptical Of
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ... 
Via StockStory
News headline image
A Fresh FDA Catalyst Is Putting Regenerative Wound Care in Focus
Issued on behalf of Conexeu Sciences Inc. 
From Equity Insider
Via GlobeNewswire
News headline image
3 Reasons to Avoid IART and 1 Stock to Buy Instead
Over the past six months, Integra LifeSciences has been a great trade, beating the S&P 500 by 25.3%. Its stock price has climbed to $17.91, representing a he... 
Via StockStory
Topics Bankruptcy Stocks
News headline image
Why Integra LifeSciences (IART) Stock Is Trading Up Today
What Happened? Shares of medical device company Integra LifeSciences (NASDAQ:IART) jumped 6.1% in the afternoon session after Citigroup upgraded its rating o... 
Via StockStory
News headline image
3 Inflated Stocks That Concern Us
The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, u... 
Via StockStory
News headline image
3 Stocks Under $50 with Open Questions
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However... 
Via StockStory
News headline image
Integra LifeSciences Says Transformation Is Working as SurgiMend Relaunch Nears ↗
Integra LifeSciences (NASDAQ:IART) is keeping its core strategy intact following a leadership change that returned Stuart to the roles of chairman and chief executive officer, Chief Financial Officer... 
Via MarketBeat
Topics Economy
News headline image
The Top 5 Analyst Questions From Integra LifeSciences’s Q1 Earnings Call
Integra LifeSciences delivered a first quarter that surpassed Wall Street expectations, as reflected by a significant positive market reaction. Management at... 
Via StockStory
Topics Earnings World Trade
News headline image
Why Are Integra LifeSciences (IART) Shares Soaring Today
What Happened? Shares of medical device company Integra LifeSciences (NASDAQ:IART) jumped 5.3% in the afternoon session after the company reported strong fir... 
Via StockStory
News headline image
Integra (IART) Q1 2026 Earnings Call Transcript ↗
Integra (IART) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings World Trade
News headline image
Integra LifeSciences (NASDAQ:IART) Exceeds Q1 CY2026 Expectations
Medical device company Integra LifeSciences (NASDAQ:IART) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 2.4% year on year to $391.9 mil... 
Via StockStory
News headline image
What To Expect From Integra LifeSciences’s (IART) Q1 Earnings
Medical device company Integra LifeSciences (NASDAQ:IART) will be reporting earnings this Tuesday before the bell. Here’s what to expect. Integra LifeScience... 
Via StockStory
News headline image
1 Value Stock to Research Further and 2 We Turn Down
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether t... 
Via StockStory
Topics Supply Chain
News headline image
3 Cash-Burning Stocks That Concern Us
Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them... 
Via StockStory
News headline image
Integra LifeSciences (IART): Buy, Sell, or Hold Post Q4 Earnings?
What a brutal six months it’s been for Integra LifeSciences. The stock has dropped 28.1% and now trades at $10.84, rattling many shareholders. This might hav... 
Via StockStory
News headline image
Q4 Rundown: Integra LifeSciences (NASDAQ:IART) Vs Other Surgical Equipment & Consumables - Specialty Stocks
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the surgical equipment & consumables - specialty stocks, including Integra LifeSciences... 
Via StockStory
Topics Artificial Intelligence Economy
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.